西妥昔单抗相关肺毒性在头颈部鳞状细胞癌同步放化疗中的病例报告
本文报告一例口咽鳞状细胞癌患者在接受西妥昔单抗同步放化疗后发生间质性肺病(ILD)和急性呼吸衰竭,经糖皮质激素治疗后完全恢复,但10个月后死于疾病复发。作者结合文献回顾指出,西妥昔单抗所致ILD虽罕见但可危及生命,早期识别和诊断至关重要。
要点
- 西妥昔单抗同步放化疗可导致罕见的间质性肺病和急性呼吸衰竭。
- 本例患者经糖皮质激素治疗后呼吸窘迫完全恢复。
- 作者认为认识该潜在副作用并早期诊断至关重要。
核心结论
- 西妥昔单抗所致间质性肺病虽罕见且文献记录不充分,但具有危及生命的影响,认识该潜在副作用并早期诊断至关重要。
研究设计与样本
- 本文为病例报告并附文献回顾,描述一例口咽鳞状细胞癌患者在西妥昔单抗同步放化疗后发生间质性肺病和急性呼吸衰竭。
主要发现
- 患者在开始西妥昔单抗同步放化疗2个月后发生急性呼吸衰竭,因进行性呼吸窘迫接受操作后收入重症监护室。
- 感染培养和血清学阴性,影像学表现符合药物相关性肺炎。
- 给予糖皮质激素直至患者稳定,患者在呼吸窘迫发作1个月后完全恢复。
- 患者在完成治疗10个月后死于疾病复发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cetuximab is a common EGFR monoclonal antibody used with radiotherapy to treat head-and-neck cancer. Severe pulmonary toxicity, including interstitial lung disease (ILD), caused by cetuximab is rare. METHODS: We describe a patient who developed ILD and acute respiratory failure after concurrent chemoradiation with cetuximab for oropharyngeal squamous cell carcinoma, and review the literature. RESULTS: A patient developed acute respiratory failure 2 months after starting concurrent chemoradiation with cetuximab and was hospitalized in intensive care after a procedure for progressive respiratory distress. Cultures and serology were negative for infection and radiologic findings were consistent with drug associated pneumonitits. Steroids were administered until the patient was stabilized. The patient fully recovered 1 month after the onset of respiratory distress, although he died of recurrent disease 10 months after completing treatment. CONCLUSION: Although severe pulmonary toxicity caused by EGFR inhibitors has been well described in the literature, ILD caused by cetuximab, an EGFR monoclonal antibody, is rare and not well-documented. Given its life-threatening effects, awareness of this potential side effect and early diagnosis is critical.
引用
- Mayfield JD, Mercado CE, Kaye FJ, et al. Cetuximab-associated pulmonary toxicity in concurrent chemoradiation for the treatment of a squamous cell carcinoma of the head and neck. Head Neck. 2019. PMID: 30614125. doi:10.1002/hed.25528
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。